EASL is the largest professional body in Europe devoted to liver health. EASL’s overarching goal is to spread knowledge and expertise in best practices and the latest scientific breakthroughs in the field of hepatology. It also advocates at national, European,…
World Liver Day, 19 April 2024 Join us in this important, international campaign
New European project aims to improve tools and advice to prevent chronic liver illnesses. Utrecht, The Netherlands, 05-02-2024: GRIPonMASH, a newly founded consortium consisting of 27 European institutions and companies, has bundled resources to bring about a transformational change in…
After over 20 years of dedicated research and drug development, the FDA has granted approval for the first anti-MASH drug. This marks a pivotal moment for patients battling MASH, whose quality of life and long-term prognosis have been greatly affected…
Liver diseases account for 300,000 deaths in Europe each year. With support from the Innovative Health Initiative, a collaboration of researchers, biotechnology companies and the pharmaceutical industry aim to improve the lives and health of people with hidden liver disease…
Triggered by the rising burden of liver disease, the Lancet and the European Association for the Study of the Liver (EASL) jointly arranged a Commission to explore the landscape of liver health in Europe. The culmination of this work was…
The European Association for the Study of the Liver (EASL), as part of the Healthy Livers, Healthy Lives Coalition held a policy webinar on 31 January 2024. Moderated by Nicola Bedlington and featuring esteemed speakers from around the world, this…
The DECISION project, an EU-funded research initiative, is making significant strides in understanding the complex dynamics of acute decompensation of cirrhosis and its progression to acute-on-chronic liver failure (ACLF). In a recent interview, Prof. Pierre-Emmanuel Rautou, DECISION Project Coordinator, provided…
Endowed with €12 million, the project is coordinated by Josep M. Llovet, the head of the IDIBAPS group Translational Research in Hepatic Oncology, a professor of Medicine at the University of Barcelona (UB) an ICREA professor. The European Union’s THRIVE…
It is with deep sorrow that EASL announces the passing of Sir Roy Calne, a pioneer in the field of transplantation. Sir Calne, a distinguished professor of surgery at Cambridge University, passed away at the age of 93. His remarkable…